Busting the myths around biosimilars Colin Howles, ARIES Consulting, Geneva, Switzerland
Dr Colin Howles is currently the founder of ARIES Consulting, based in Geneva, Switzerland. ARIES Consulting has since 2013, been providing services to device and pharmaceutical companies in the Fertility therapeutic area, including Theramex, as well as working directly with in-vitro fertilisation (IVF) clinics across the world. He is also an Honorary Fellow in the Deanery of Biomedical Sciences, the University of Edinburgh where he participates in the undergraduate teaching program and research supervision.
Dr Howles has worked for 44 years in the field of Reproductive Endocrinology and Medicine. He obtained a PhD from Nottingham University, UK and started working at the first human IVF clinic in the world, Bourn Hall Clinic, Cambridge UK in the early 1980s.
He then spent 25 years in the biopharmaceutical industry and was involved in the development and worldwide clinical introduction of the first recombinant h-FSH (follitropin alfa), h-LH (lutropin alfa) and hCG (choriogonadotropin alfa). In total, he has had experience of introducing into clinical use six recombinant gonadotrophin preparations.